Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides
15/10/2025 18:12
Oct 15 (Reuters) - Adocia SA ADOC.PA: ADOCIA REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE ADOCIA SA - CASH RUNWAY SECURED UNTIL Q2 2026 ADOCIA SA: NOW SEEING CHALLENGES WITH GLP-1, AMYLIN, AND OTHER METABOLIC PEPTIDES Source text: ID:nBw52Fl88a Further company coverage: ADOC.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adocia SA
See all newsFrench biopharma firm Adocia H1 revenue drops on weaker feasibility study income
Brief: Adocia H1 Operating Income EUR -7.947 Million
Brief: Adocia Says Sanofi’S Exclusive Right For Partnership Agreement For Development Of M1Pram Has Expired
Brief: Adocia And Vester Finance Sign Shareholder Loan Agreement
Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides